Search
Neumora Therapeutics Inc
NMRAAdd to Watchlist
0.698USD
-0.033-4.51%
Market hours 09/24, 14:29（ET）
129.33MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-4.51%
5 Days
-9.70%
1 Month
-57.18%
6 Months
-71.74%
Year to Date
-61.01%
1 Year
-63.46%
Key Figures
0.748Open
0.779High
93.98KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
0.731Prev. Close
0.690Low
66.84KTurnover
LossP/E Static
2.90P/B
0.00%Div Yield TTM
-108.32%ROA
3.65052wk High
0.04Volume Ratio
-243.79MNet Profit
185.28MShares
-1.3261EPS TTM
--Beta
-148.74%ROE
0.68152wk Low
12.18%Amplitude
--Gross Margin
129.33MMarket Cap
-0.28Reward/Risk
7.98%Risk Rate
More news coming soon, stay tuned...
Analyst Rating
Neumora Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.23/-0.24
Revenue / Forecast
--/0.00
Neumora Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolNMRA
Number of employees110
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Amgen Inc | 19.09% |
| ARCH Venture Partners | 18.27% |
| Invus Public Equities Advisors, LLC | 4.59% |
| Berns (Paul L) | 4.16% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 21.86% |
| Venture Capital | 19.33% |
| Corporation | 19.09% |
| Hedge Fund | 7.86% |
Related Instruments
+3.26%
+1.15%
+0.11%
+0.74%
+0.61%
+1.56%
+0.41%
-0.38%
+0.45%
+0.98%
+1.21%
-0.54%
-0.32%
+0.22%
-1.54%
-0.48%
+2.78%
+1.11%
-1.04%
+1.63%
FAQs
What is the current price of Neumora Therapeutics Inc (NMRA)?
The current price of Neumora Therapeutics Inc (NMRA) is 0.73.
What is the symbol of Neumora Therapeutics Inc?
The ticker symbol of Neumora Therapeutics Inc is NMRA.
What is the 52-week high of Neumora Therapeutics Inc?
The 52-week high of Neumora Therapeutics Inc is 3.65.
What is the 52-week low of Neumora Therapeutics Inc?
The 52-week low of Neumora Therapeutics Inc is 0.68.
What is the market capitalization of Neumora Therapeutics Inc?
The market capitalization of Neumora Therapeutics Inc is 135.44M.
Is Neumora Therapeutics Inc (NMRA) currently rated as Buy, Hold, or Sell?
According to analysts, Neumora Therapeutics Inc (NMRA) has an overall rating of Buy, with a price target of 6.14.
What is the Earnings Per Share (EPS TTM) of Neumora Therapeutics Inc (NMRA)?
The Earnings Per Share (EPS TTM) of Neumora Therapeutics Inc (NMRA) is -1.33.